204 related articles for article (PubMed ID: 29108299)
1. Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Hiyoshi Y; Akiyoshi T; Inoue R; Murofushi K; Yamamoto N; Fukunaga Y; Ueno M; Baba H; Mori S; Yamaguchi T
Oncotarget; 2017 Oct; 8(45):79201-79211. PubMed ID: 29108299
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer.
Du B; Wang X; Wu D; Wang T; Yang X; Wang J; Shi X; Chen L; Zhang W
Mol Med Rep; 2018 Aug; 18(2):1909-1916. PubMed ID: 29956755
[TBL] [Abstract][Full Text] [Related]
4. Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis.
Croner RS; Sevim M; Metodiev MV; Jo P; Ghadimi M; Schellerer V; Brunner M; Geppert C; Rau T; Stürzl M; Naschberger E; Matzel KE; Hohenberger W; Lottspeich F; Kellermann J
Int J Mol Sci; 2016 Feb; 17(2):209. PubMed ID: 26861291
[TBL] [Abstract][Full Text] [Related]
5. Serum hsa-miR-30e As a Potential Biomarker to Predict the Effect of Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer.
Chen W; Wang W
Genet Test Mol Biomarkers; 2021 Nov; 25(11):696-706. PubMed ID: 34788143
[No Abstract] [Full Text] [Related]
6. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer.
Jia H; Shen X; Guan Y; Xu M; Tu J; Mo M; Xie L; Yuan J; Zhang Z; Cai S; Zhu J; Zhu Z
Radiother Oncol; 2018 Sep; 128(3):548-556. PubMed ID: 30041962
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
8. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
Ryan JE; Warrier SK; Lynch AC; Ramsay RG; Phillips WA; Heriot AG
Colorectal Dis; 2016 Mar; 18(3):234-46. PubMed ID: 26531759
[TBL] [Abstract][Full Text] [Related]
9. Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Momma T; Okayama H; Kanke Y; Fukai S; Onozawa H; Fujita S; Sakamoto W; Saito M; Ohki S; Kono K
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572869
[TBL] [Abstract][Full Text] [Related]
10. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Marinkovic M; Stojanovic-Rundic S; Stanojevic A; Ostojic M; Gavrilovic D; Jankovic R; Maksimovic N; Stroggilos R; Zoidakis J; Castellví-Bel S; Fijneman RJA; Cavic M
Front Genet; 2023; 14():1245594. PubMed ID: 37719698
[No Abstract] [Full Text] [Related]
11. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
Lopes-Ramos C; Koyama FC; Habr-Gama A; Salim AC; Bettoni F; Asprino PF; França GS; Gama-Rodrigues J; Parmigiani RB; Perez RO; Galante PA; Camargo AA
Cancer Genet; 2015 Jun; 208(6):319-26. PubMed ID: 25963525
[TBL] [Abstract][Full Text] [Related]
12. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.
Dayde D; Tanaka I; Jain R; Tai MC; Taguchi A
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272347
[TBL] [Abstract][Full Text] [Related]
13. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
14. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
[TBL] [Abstract][Full Text] [Related]
15. Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.
Repetto O; De Re V; De Paoli A; Belluco C; Alessandrini L; Canzonieri V; Cannizzaro R
Oncotarget; 2017 Apr; 8(17):28328-28341. PubMed ID: 28423701
[TBL] [Abstract][Full Text] [Related]
16. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Della Vittoria Scarpati G; Falcetta F; Carlomagno C; Ubezio P; Marchini S; De Stefano A; Singh VK; D'Incalci M; De Placido S; Pepe S
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1113-9. PubMed ID: 22172905
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammatory indices predict tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Lai S; Huang L; Luo S; Liu Z; Dong J; Wang L; Kang L
Oncol Lett; 2020 Sep; 20(3):2763-2770. PubMed ID: 32782593
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.
Kim HJ; Bae SB; Jeong D; Kim ES; Kim CN; Park DG; Ahn TS; Cho SW; Shin EJ; Lee MS; Baek MJ
Oncol Rep; 2014 Dec; 32(6):2493-500. PubMed ID: 25241658
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy.
Wang H; Ji D; Tian H; Gao Z; Song C; Jia J; Cui X; Zhong L; Shen J; Gu J
BMC Cancer; 2022 Aug; 22(1):868. PubMed ID: 35945555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]